Evaluation of Quality of Life (QoL) in Subjects With Highly Active Relapsing Multiple Sclerosis (MS) (CLARIFY MS)
NCT03369665
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
485
Enrollment
INDUSTRY
Sponsor class
Conditions
Multiple Sclerosis
Interventions
DRUG:
Mavenclad®
Sponsor
Merck KGaA, Darmstadt, Germany